After nearly a year of vacancy, the Senate has chosen Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention as its 22nd director on Wednesday, August 5, 2026. This decision comes after Schwartz previously served as deputy surgeon general under the first iteration of the Trump administration, with many of her votes coming from Republicans in a 51-44 poll result, as reported by NBC News.
While Schwartz’s decorated background as Chief Medical Officer in the Coast Guard, a Navy physician, and Deputy Surgeon General were factors considered during the selection process, her alignment with President Donald Trump alongside other Republicans has made many citizens concerned about what her performance in the role will look like.
After a recent Senate hearing tied to her nomination, her responses to questions on topics such as vaccines and public health policies left listeners feeling as though certain things went unanswered or that Schwartz didn’t outline a firm stance in some areas. During the hearing, Schwartz even noted not fully being aware of Robert F. Kennedy Jr.’s vaccine policy changes nor fully opposing his stances since his appointment as United States Secretary of Health and Human Services.
Though her credentials show the depth of her qualifications for the position, many have taken to social media to voice their concerns regarding her appointment. “I am extremely concerned about her appointment given the fact that she refused to respond clearly to questions about vaccines and more concerning – she committed to creating an abortion registry which would be a steady stream of targets for our government to retaliate against. I hope she proves to us that she will protect us, not the wills of a cruel administration,” one user on Instagram commented on a post highlighting Schwartz’s emphasis on her commitment to science in her new role.
Others have also noted a separate stream of concern as being the first Black woman in the role as other Black people in government roles have stripped from their leadership titles under the Trump administration. This has put into question not only political leadership’s true intentions in having her in the role, but also the hope that this is not a ploy to take the mantle of health mishaps pushed by the administration. The hope many have is that she advocates for minority health concerns and earns the trust of the American people.
“So, I definitely understand where you’re coming from, but if she had given acceptable answers that contradicted RFK at all, her nomination would have been pulled. Just look at what happened to Dr. Monarez. I get the hesitancy but I’m hopeful she was just trying to toe an impossible line,” a user on Reddit expressed in a thread in response to a comment regarding someone wishing they could celebrate Schwartz’s appointment.
Schwartz’s term is to start immediately now that voting has concluded and the appointment has been confirmed.